Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

NCT00191204 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence Stress

Interventions

DRUG: Duloxetine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]